dc.contributor.author | Washington, Neena | |
dc.contributor.author | Washington, Clive | |
dc.contributor.author | Wilson, Clive | |
dc.date.accessioned | 2019-11-07T06:20:32Z | |
dc.date.available | 2019-11-07T06:20:32Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Washington, Neena, Washington, Clive & Wilson, Clive (2001). Physiological pharmaceutics: barriers to drug absorption. 2nd ed. London :Taylor & Francis. | en_US |
dc.identifier.isbn | 0-203-79194-0 | |
dc.identifier.uri | http://hdl.handle.net/123456789/1325 | |
dc.description.abstract | In recent years, the emphasis in drug development has been the design of new delivery systems rather than new drugs. It is the aim of innovative pharmaceutical scientists to design the new dosage forms to overcome the body's barrier mechanisms which have specifically evolved to exclude foreign material. This book provides an integrated approach to the study of drug formulation in the body with the emphasis on the formulation variables rather than the drugs. The link between physiology and pharmaceutics is presented to give an essential background of biological principles for the pharmacy student, pharmaceutical formulator and healthcare professional. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.subject | Drugs—Bioavailability | en_US |
dc.subject | Drugs—Dosage forms | en_US |
dc.subject | Drugs—Physiological transport | en_US |
dc.title | Physiological pharmaceutics: barriers to drug absorption | en_US |
dc.type | Book | en_US |